115 related articles for article (PubMed ID: 8048505)
1. Direct plasma radioimmunoassay for rat amylin-(1-37): concentrations with acquired and genetic obesity.
Pieber TR; Roitelman J; Lee Y; Luskey KL; Stein DT
Am J Physiol; 1994 Jul; 267(1 Pt 1):E156-64. PubMed ID: 8048505
[TBL] [Abstract][Full Text] [Related]
2. Hypersecretion of amylin from the perfused pancreas of genetically obese (fa/fa) rats and its alteration with aging.
Inoue K; Hiramatsu S; Hisatomi A; Umeda F; Nawata H
Metabolism; 1993 May; 42(5):654-8. PubMed ID: 8492723
[TBL] [Abstract][Full Text] [Related]
3. Developmental regulation of amylin and insulin-gene expression in lean (Fa/Fa) and obese (fa/fa) Zucker rats.
Koranyi L; Tanizawa Y; Penicaud L; Atef N; Girard J; Permutt MA
Diabetes; 1992 Jun; 41(6):685-90. PubMed ID: 1375176
[TBL] [Abstract][Full Text] [Related]
4. Plasma amylin concentrations in fasted and fed rats quantified by a monoclonal immunoenzymometric assay.
Vine W; Blase E; Koda J; Young A
Horm Metab Res; 1998 Sep; 30(9):581-5. PubMed ID: 9808328
[TBL] [Abstract][Full Text] [Related]
5. Beta-cell tropin- and glucose-induced hypersecretion of insulin and amylin from perfused fatty rat pancreas.
Dunmore SJ; Cawthorne MA; Hislop DC; Morton JL; Beloff-Chain A
J Endocrinol; 1993 Jun; 137(3):375-81. PubMed ID: 8396617
[TBL] [Abstract][Full Text] [Related]
6. Plasma amylin and insulin concentrations in normoglycemic and hyperglycemic cats.
Lutz TA; Rand JS
Can Vet J; 1996 Jan; 37(1):27-34. PubMed ID: 8746416
[TBL] [Abstract][Full Text] [Related]
7. Influence of high-fat feeding, diet-induced obesity, and hyperamylinemia on the sensitivity to acute amylin.
Boyle CN; Rossier MM; Lutz TA
Physiol Behav; 2011 Jul; 104(1):20-8. PubMed ID: 21550355
[TBL] [Abstract][Full Text] [Related]
8. Hyperamylinemia, hyperinsulinemia, and insulin resistance in genetically obese LA/N-cp rats.
Huang HJ; Young AA; Koda JE; Tulp OL; Johnson MJ; Cooper GJ
Hypertension; 1992 Jan; 19(1 Suppl):I101-9. PubMed ID: 1730446
[TBL] [Abstract][Full Text] [Related]
9. Evidence that amylin stimulates lipolysis in vivo: a possible mediator of induced insulin resistance.
Ye JM; Lim-Fraser M; Cooney GJ; Cooper GJ; Iglesias MA; Watson DG; Choong B; Kraegen EW
Am J Physiol Endocrinol Metab; 2001 Apr; 280(4):E562-9. PubMed ID: 11254462
[TBL] [Abstract][Full Text] [Related]
10. Insulin-like growth factor-I inhibits insulin and amylin secretion in conscious rats.
Fürnsinn C; Alma M; Roden M; Pieber T; Nowotny P; Schneider B; Waldhäusl W
Endocrinology; 1994 Nov; 135(5):2144-9. PubMed ID: 7956938
[TBL] [Abstract][Full Text] [Related]
11. Coordinate regulation of amylin and insulin expression in response to hypoglycemia and fasting.
Alam T; Chen L; Ogawa A; Leffert JD; Unger RH; Luskey KL
Diabetes; 1992 Apr; 41(4):508-14. PubMed ID: 1607075
[TBL] [Abstract][Full Text] [Related]
12. 8-37hCGRP, an amylin receptor antagonist, enhances the insulin response and perturbs the glucose response to infused arginine in anesthetized rats.
Young AA; Carlo P; Rink TJ; Wang MW
Mol Cell Endocrinol; 1992 Mar; 84(1-2):R1-5. PubMed ID: 1322328
[TBL] [Abstract][Full Text] [Related]
13. Human aging is associated with parallel reductions in insulin and amylin release.
Dechenes CJ; Verchere CB; Andrikopoulos S; Kahn SE
Am J Physiol; 1998 Nov; 275(5):E785-91. PubMed ID: 9814997
[TBL] [Abstract][Full Text] [Related]
14. Amylin tonally regulates arginine-stimulated insulin secretion in rats.
Bennet WM; Beis CS; Ghatei MA; Byfield PG; Bloom SR
Diabetologia; 1994 Apr; 37(4):436-8. PubMed ID: 8063047
[TBL] [Abstract][Full Text] [Related]
15. Amylin-insulin relationships in insulin resistance with and without diabetic hyperglycemia.
Pieber TR; Stein DT; Ogawa A; Alam T; Ohneda M; McCorkle K; Chen L; McGarry JD; Unger RH
Am J Physiol; 1993 Sep; 265(3 Pt 1):E446-53. PubMed ID: 8105694
[TBL] [Abstract][Full Text] [Related]
16. Cosecretion of amylin and insulin from isolated rat pancreas.
Fehmann HC; Weber V; Göke R; Göke B; Arnold R
FEBS Lett; 1990 Mar; 262(2):279-81. PubMed ID: 2185950
[TBL] [Abstract][Full Text] [Related]
17. Chronic infusion of the amylin antagonist AC 187 increases feeding in Zucker fa/fa rats but not in lean controls.
Grabler V; Lutz TA
Physiol Behav; 2004 May; 81(3):481-8. PubMed ID: 15135020
[TBL] [Abstract][Full Text] [Related]
18. Circulating amylin in human essential hypertension: heritability and early increase in individuals at genetic risk.
Kailasam MT; Parmer RJ; Tyrell EA; Henry RR; O'Connor DT
J Hypertens; 2000 Nov; 18(11):1611-20. PubMed ID: 11081774
[TBL] [Abstract][Full Text] [Related]
19. Dose-response for glucagonostatic effect of amylin in rats.
Gedulin BR; Rink TJ; Young AA
Metabolism; 1997 Jan; 46(1):67-70. PubMed ID: 9005972
[TBL] [Abstract][Full Text] [Related]
20. Response to intravenous injections of amylin and glucagon in fasted, fed, and hypoglycemic rats.
Young AA; Cooper GJ; Carlo P; Rink TJ; Wang MW
Am J Physiol; 1993 Jun; 264(6 Pt 1):E943-50. PubMed ID: 8333519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
